The steric effect of bulky groups of the catalyst can kinetically suppress the transesterification reactions by screening linear polymer chains from the active center during the polymerization of ε-caprolactone (CL) with rare earth alkoxide. Therefore, isopropoxy rare earth diethyl acetoacetate ((EA) 2 LnOiPr Ln = Nd, Y) and Nd(OiPr) 3 -donor adducts (1,10-phenanthroline, 2,2‘-bipyridyl, 18-crown-6 ether) are excellent catalysts for the living polymerization of ε-caprolactone, giving poly(ε-caprolactone) (PCL) with a narrow molecular weight distribution. Block copolymerizations of ε-caprolactone with trimethylene carbonate (TMC) and d, l -lactide (LA) have been attained successfully using (EA) 2 LnOiPr as catalyst. The characterizations by GPC, NMR, DSC, and polarizing microscope showed that the block copolymers, P(CL- b -TMC) and P(CL- b - d, l -lactide), have well-controlled sequences without random placement.
No takes yet. Share an insight, caveat, or question.
Shen et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: